Format

Send to

Choose Destination
See comment in PubMed Commons below
Mol Diagn Ther. 2013 Apr;17(2):71-84. doi: 10.1007/s40291-013-0023-x.

Bladder cancer detection and monitoring: assessment of urine- and blood-based marker tests.

Author information

1
Cancer Research Institute, MD Anderson Cancer Center Orlando, 6900 Lake Nona Blvd, Orlando, FL 32827, USA. steven.goodison@orlandohealth.com

Abstract

Bladder cancer is one of the most prevalent cancers worldwide, but the treatment and management of this disease can be very successful if the disease is detected early. The development of molecular assays that could diagnose bladder cancer accurately, and at an early stage, would be a significant advance. Ideally, such molecular assays would be applicable to non-invasively obtained body fluids, and be designed not only for diagnosis but also for monitoring disease recurrence and response to treatment. In this article, we assess the performance of current diagnostic assays for bladder cancer and discuss some of the emerging biomarkers that could be developed to augment current bladder cancer detection strategies.

PMID:
23479428
PMCID:
PMC3627848
DOI:
10.1007/s40291-013-0023-x
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Support Center